back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-07-01 23:56 Tx date 2025-06-26 |
$NIRV
Nirvana Life Sciences In. |
Inwentash, Sheldon
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: ThreeD Capital (Control or Direction)
|
Warrants
37 - Stock split or consolidation
|
+50,000 vol |
50,000 | |
| Filed 2025-07-01 23:55 Tx date 2025-06-26 |
$NIRV
Nirvana Life Sciences In. |
Inwentash, Sheldon
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: ThreeD Capital (Control or Direction)
|
Warrants
37 - Stock split or consolidation
|
-500,000 vol |
0 | |
| Filed 2025-07-01 23:53 Tx date 2025-06-05 |
$NIRV
Nirvana Life Sciences In. |
Inwentash, Sheldon
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: ThreeD Capital (Control or Direction)
|
Warrants
37 - Stock split or consolidation
|
-500,000 vol |
||
| Filed 2025-07-01 23:52 Tx date 2025-06-05 |
$NIRV
Nirvana Life Sciences In. |
Inwentash, Sheldon
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: ThreeD Capital (Control or Direction)
|
Warrants
37 - Stock split or consolidation
|
-500,000 vol |
||
| Filed 2025-07-01 23:44 Tx date 2025-06-26 |
$NIRV
Nirvana Life Sciences In. |
Inwentash, Jakson Samuel
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+20,000 vol |
20,000 | |
| Filed 2025-07-01 23:44 Tx date 2025-06-26 |
$NIRV
Nirvana Life Sciences In. |
Inwentash, Jakson Samuel
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-200,000 vol |
0 | |
| Filed 2025-07-01 23:40 Tx date 2025-06-26 |
$NIRV
Nirvana Life Sciences In. |
Inwentash, Sheldon
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+20,000 vol |
20,000 | |
| Filed 2025-07-01 23:39 Tx date 2025-06-26 |
$NIRV
Nirvana Life Sciences In. |
Inwentash, Sheldon
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-200,000 vol |
0 | |
| Filed 2025-06-10 23:13 Tx date 2025-06-05 |
$NIRV
Nirvana Life Sciences In. |
Inwentash, Sheldon
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: ThreeD Capital (Control or Direction)
|
Warrants
55 - Expiration of warrants
|
-500,000 vol |
||
| Filed 2025-06-20 22:09 Tx date 2025-06-16 |
$NIRV
Nirvana Life Sciences In. |
Inwentash, Jakson Samuel
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
+50,000 vol |
50,000 | |
| Filed 2025-06-20 22:09 Tx date 2025-06-16 |
$NIRV
Nirvana Life Sciences In. |
Inwentash, Jakson Samuel
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-500,000 vol |
0 | |
| Filed 2025-06-20 21:25 Tx date 2025-06-16 |
$NIRV
Nirvana Life Sciences In. |
Inwentash, Sheldon
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: ThreeD Capital (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
+357,500 vol |
357,500 | |
| Filed 2025-06-20 21:25 Tx date 2025-06-16 |
$NIRV
Nirvana Life Sciences In. |
Inwentash, Sheldon
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: ThreeD Capital (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-3,575,000 vol |
0 | |
| Filed 2025-06-20 21:16 Tx date 2025-06-16 |
$NIRV
Nirvana Life Sciences In. |
Inwentash, Sheldon
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
+150,000 vol |
150,000 | |
| Filed 2025-06-20 21:15 Tx date 2025-06-16 |
$NIRV
Nirvana Life Sciences In. |
Inwentash, Sheldon
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-1,500,000 vol |
0 | |
| Filed 2025-06-10 23:13 Tx date 2025-06-05 |
$NIRV
Nirvana Life Sciences In. |
Inwentash, Sheldon
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: ThreeD Capital (Control or Direction)
|
Warrants
55 - Expiration of warrants
|
-500,000 vol |
0 | |
| Filed 2025-04-03 18:14 Tx date 2025-04-03 |
$NIRV
Nirvana Life Sciences In. |
Clark, Bruce Andrew James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Vobis Consulting Group Inc. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-5,720,999 vol |
635,667 | |
| Filed 2025-04-03 18:13 Tx date 2017-12-08 |
$NIRV
Nirvana Life Sciences In. |
Clark, Bruce Andrew James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Vobis Consulting Group Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
6,356,666 | ||
| Filed 2025-04-03 18:01 Tx date 2025-04-03 |
$NIRV
Nirvana Life Sciences In. |
Clark, Bruce Andrew James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$-405,000
-270,000 vol $1.50 each |
80,000 | |
| Filed 2023-11-16 01:04 Tx date 2023-11-10 |
$NIRV
Nirvana Life Sciences In. |
Clark, Bruce Andrew James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+2,650,000 vol |
6,356,666 | |
| Filed 2023-05-18 14:41 Tx date 2023-05-17 |
$NIRV
Nirvana Life Sciences In. |
Clark, Bruce
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$100,000
+2,000,000 vol $0.05 each |
3,706,666 | |
| Filed 2023-05-17 13:47 Tx date 2023-05-12 |
$NIRV
Nirvana Life Sciences In. |
Fretwell, Gordon
5 - Senior Officer of Issuer
Holder: Gordon J. Fretwell Law Corporation (Control or Direction)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$20,000
+400,000 vol $0.05 each |
400,000 | |
| Filed 2023-05-17 13:46 Tx date 2015-03-23 |
$NIRV
Nirvana Life Sciences In. |
Fretwell, Gordon
5 - Senior Officer of Issuer
Holder: Gordon J. Fretwell Law Corporation (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-05-11 14:47 Tx date 2023-05-10 |
$NIRV
Nirvana Life Sciences In. |
Storey, Annie
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$45,000
+300,000 vol $0.15 each |
350,000 | |
| Filed 2023-05-05 14:20 Tx date 2023-05-01 |
$NIRV
Nirvana Life Sciences In. |
Clark, Bruce
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$45,000
+300,000 vol $0.15 each |
350,000 | |
| Filed 2023-02-27 21:43 Tx date 2023-02-22 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
Inwentash, Jakson Samuel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
200,000 | |
| Filed 2023-02-27 21:37 Tx date 2022-06-08 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
Inwentash, Jakson Samuel
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-02-27 21:34 Tx date 2023-02-22 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
Inwentash, Sheldon
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
200,000 | |
| Filed 2023-02-27 21:32 Tx date 2022-03-17 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
Inwentash, Sheldon
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-02-21 13:21 Tx date 2023-02-06 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
McCune, Michael Grant
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,540
-106,000 vol $0.09 each |
1,401,143 | |
| Filed 2023-02-21 13:15 Tx date 2022-03-17 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
McCune, Michael Grant
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,507,143 | ||
| Filed 2022-08-15 19:39 Tx date 2022-08-08 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
Storey, Annie
4 - Director of Issuer
Holder: Ginger Fire Media Finance Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,925
-5,500 vol $0.35 each |
370,000 | |
| Filed 2022-08-09 20:48 Tx date 2022-08-05 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
Inwentash, Jakson Samuel
4 - Director of Issuer
Holder: Bristlecone Pine Inc. (Control or Direction)
|
Options
50 - Grant of options
|
+300,000 vol |
300,000 | |
| Filed 2022-08-09 20:46 Tx date 2022-06-08 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
Inwentash, Jakson Samuel
4 - Director of Issuer
Holder: Bristlecone Pine Inc. (Control or Direction)
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-07-13 15:28 Tx date 2022-07-07 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
Storey, Annie
4 - Director of Issuer
Holder: Ginger Fire Media Finance Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,822.50
-4,500 vol $0.405 each |
375,500 | |
| Filed 2022-06-11 00:43 Tx date 2022-06-09 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
Inwentash, Sheldon
3 - 10% Security Holder of Issuer
Holder: ThreeD Capital (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,640
+25,000 vol $0.59 each |
3,575,000 | |
| Filed 2022-06-11 00:40 Tx date 2022-06-09 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
ThreeD Capital Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,640
+25,000 vol $0.59 each |
3,575,000 | |
| Filed 2022-06-11 00:38 Tx date 2022-06-08 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
ThreeD Capital Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
3,550,000 | ||
| Filed 2022-06-11 00:27 Tx date 2022-06-08 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
Inwentash, Jakson Samuel
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-11 00:27 Tx date 2022-06-08 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
Inwentash, Jakson Samuel
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
| Filed 2022-06-11 00:20 Tx date 2022-06-08 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
ThreeD Capital Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
| Filed 2022-06-11 00:19 Tx date 2022-06-08 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
ThreeD Capital Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-09 22:47 Tx date 2022-06-08 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
Inwentash, Sheldon
3 - 10% Security Holder of Issuer
Holder: ThreeD Capital (Control or Direction)
|
Warrants
10 - Acquisition or disposition in the public market
|
+500,000 vol |
500,000 | |
| Filed 2022-06-09 22:46 Tx date 2022-03-17 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
Inwentash, Sheldon
3 - 10% Security Holder of Issuer
Holder: ThreeD Capital (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-09 22:44 Tx date 2022-06-08 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
Inwentash, Sheldon
3 - 10% Security Holder of Issuer
Holder: ThreeD Capital (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$150,000
+500,000 vol $0.30 each |
3,550,000 | |
| Filed 2022-06-09 22:41 Tx date 2022-06-08 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
Inwentash, Sheldon
3 - 10% Security Holder of Issuer
Holder: ThreeD Capital (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$150,000
+500,000 vol $0.30 each |
||
| Filed 2022-06-08 23:37 Tx date 2022-06-03 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
Inwentash, Sheldon
3 - 10% Security Holder of Issuer
Holder: ThreeD Capital (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$29,750
+50,000 vol $0.59 each |
3,050,000 | |
| Filed 2022-06-08 18:59 Tx date 2022-06-06 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
Storey, Annie
4 - Director of Issuer
Holder: Ginger Fire Media Finance Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,000
-10,000 vol $0.60 each |
380,000 | |
| Filed 2022-06-08 18:59 Tx date 2022-06-03 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
Storey, Annie
4 - Director of Issuer
Holder: Ginger Fire Media Finance Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,500
-10,000 vol $0.55 each |
390,000 | |
| Filed 2022-06-08 02:10 Tx date 2022-06-03 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
Hang, Connie Lai
5 - Senior Officer of Issuer
Holder: Excellere Financial Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,950
-5,000 vol $0.59 each |
293,000 | |
| Filed 2022-04-13 20:37 Tx date 2022-04-11 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
Hang, Connie Lai
5 - Senior Officer of Issuer
Holder: Excellere Financial Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,250
-15,000 vol $0.55 each |
298,000 | |
| Filed 2022-04-13 20:30 Tx date 2022-04-08 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
Hang, Connie Lai
5 - Senior Officer of Issuer
Holder: Excellere Financial Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,520
-7,000 vol $0.36 each |
313,000 | |
| Filed 2022-03-22 18:43 Tx date 2022-03-16 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
Storey, Annie
4 - Director of Issuer
Holder: Ginger Fire Media Finance Corp. (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$88,000
+400,000 vol $0.22 each |
400,000 | |
| Filed 2022-03-22 17:37 Tx date 2022-03-16 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
Storey, Annie
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$12,500
+50,000 vol $0.25 each |
50,000 | |
| Filed 2022-03-22 17:35 Tx date 2022-03-16 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
Storey, Annie
4 - Director of Issuer
Holder: Ginger Fire Media Finance Corp. (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$8,800,000
+400,000 vol $22.00 each |
||
| Filed 2022-03-22 17:35 Tx date 2022-03-16 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
Storey, Annie
4 - Director of Issuer
Holder: Ginger Fire Media Finance Corp. (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$8,800,000
+400,000 vol $22.00 each |
400,000 | |
| Filed 2022-03-22 17:31 Tx date 2015-10-01 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
Storey, Annie
4 - Director of Issuer
Holder: Ginger Fire Media Finance Corp. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-03-19 04:13 Tx date 2022-03-17 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
Inwentash, Sheldon
3 - 10% Security Holder of Issuer
Holder: ThreeD Capital (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
3,000,000 | ||
| Filed 2022-03-19 04:11 Tx date 2022-03-17 |
$NIRV
Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) |
Inwentash, Sheldon
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,500,000 |